Organic electroluminescent materials and devices
US-10230060-B2 · Mar 12, 2019 · US
US11196010B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11196010-B2 |
| Application number | US-201715706186-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 15, 2017 |
| Priority date | Oct 3, 2016 |
| Publication date | Dec 7, 2021 |
| Grant date | Dec 7, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Novel phosphorescent metal complexes containing ligands having the Formula I: bearing either a naphthalene or other fused heterocycle moieties such as benzofuran and benzothiophene useful as emitters in OLEDs and improve the device efficiency and the FWHM of the emission.
Opening claim text (preview).
We claim: 1. A neutral compound that has a structure of formula (L A ) n Ir(L B ) 3-n ; wherein L B is a bidentate ligand; wherein n is 1, 2, or 3; and wherein ligand L A has a structure of Formula I: wherein Ring B represents a five- or six-membered aromatic ring; wherein R 3 represents from none to the maximum number of substitutions; wherein X 1 , X 2 , X 3 , and X 4 are each independently a CR or N; wherein at least one of X 1 , X 2 , or X 3 is nitrogen; wherein (a) R 1 is CR 11 R 12 R 13 or joins with R 2 to form into a ring; or (b) R 2 is not hydrogen, or (c) both (a) and (b) are true; wherein R, R 1 , R 2 , R 11 , R 12 , R 13 are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein, with the exception of a ring between R and R 2 , any two substituents among R, R 1 , R 2 , R 11 , R 12 , R 13 are optionally joined to form into an aromatic ring; wherein L A is coordinated to a metal M; wherein L A is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; wherein M is optionally coordinated to other ligands; and wherein L B is C 1 to C 7 alkyl substituted or unsubstituted acetylacetonate. 2. The neutral compound of claim 1 , wherein M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu. 3. The neutral compound of claim 1 , wherein M is Ir or Pt. 4. The neutral compound of claim 1 , wherein X 2 is nitrogen. 5. The neutral compound of claim 1 , wherein R 1 is tert-butyl or substituted tert-butyl. 6. The neutral compound of claim 1 , wherein R 1 and R 2 form into an aromatic ring, which can be further substituted. 7. The neutral compound of claim 1 , wherein R 2 is selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, and combination thereof. 8. The neutral compound of claim 1 , wherein Ring B is phenyl. 9. The neutral compound of claim 1 , wherein the ligand L A is selected from the group consisting of: wherein X is S or O; wherein Y is N; wherein R 1 , R 2 , R 9 , R 10 , R 11 , R 12 , R 13 , and R 14 are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two substituents are optionally joined to form into a ring. 10. The neutral compound of claim 1 , wherein L B is selected from the group consisting of: 11. The neutral compound of claim 1 , wherein at least two adjacent ones of X 1 , X 2 , X 3 , and X 4 are CR and are fused into a five-membered aromatic ring. 12. The neutral compound of claim 1 , wherein at least two adjacent ones of X 1 , X 2 , X 3 , and X 4 are CR and are fused into a six-membered aromatic ring. 13. The neutral compound of claim 1 , wherein the ligand L A is selected from the group consisting of: L A391 through L A520 that are based on a structure of Formula III, in which R 1 , R 9 , R 10 , and Y are defined as provided below: Ligand R 1 R 9 R 10 Y L A391 R B6 H H N L A392 R B6 R B1 H N L A393 R B6 R B3 H N L A394 R B6 R B4 H N L A395 R B6 R B7 H N L A396 R B6 R B10 H N L A397 R B6 R A3 H N L A398 R B6 R A34 H N L A399 R B6 H R B1 N L A400 R B6 H R B2 N L A401 R B6 H R B3 N L A402 R B6 H R B4 N L A403 R B6 H R B7 N L A404 R B6 H R B10 N L A405 R B6 H R A3 N L A406 R B6 H R A34 N L A407 R B6 R B1 R B1 N L A408 R B6 R B3 R B3 N
comprising dopants · CPC title
comprising iridium · CPC title
of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title
containing organic luminescent materials · CPC title
Iridium compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.